ORPHA:180079
Pseudounicornuate uterus
Also known as: Incomplete unilateral Müllerian aplasia · Incomplete unilateral aplasia of the Müllerian ducts · Unicornuate uterus with rudimentary horn
Publications
83
51.6th percentile
Trials
0
Interventional, condition-specific
Researchers
373
Distinct authors in sample
Gene link
—
Readiness
1/6
Stages with a signal
Clinical definition (Orphanet)
A rare, non-syndromic uterovaginal characterized by a crescent-shaped, small-sized uterus containing a single horn and fallopian tube associated with a rudimentary second horn (which can be solid or contain a cavity with functioning endometrium and be communicating or non-communicating). Urinary tract anomalies are frequently associated.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0015833
- UMLS:C4749300
Additional Mondo synonyms (5)
incomplete unilateral Mullerian aplasia · incomplete unilateral Müllerian aplasia · incomplete unilateral aplasia of the Mullerian ducts · incomplete unilateral aplasia of the Müllerian ducts · unicornuate uterus with rudimentary horn
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
1/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
83 matched papers (45 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
83
83 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
83 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
45 in the last 10 years · high confidence · 51.6th percentile (publications denominator)
Phrase hits: 83 · MeSH hits: 0
Who's working on it?
373
Distinct author names in 83 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Ahmadi F4 papers · 2014
Department of Reproductive Imaging at Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Papers in Europe PMC - 02Zhang X3 papers · 2024
Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, 100191, China.
Papers in Europe PMC - 03Chen S2 papers · 2025
Department of Ultrasonic Medicine, Changsha Maternal and Child Health Hospital, Changsha, China.
Papers in Europe PMC - 04Duan X2 papers · 2025
Department of Ultrasonic Medicine, Changsha Maternal and Child Health Hospital, Changsha, China.
Papers in Europe PMC - 05Gupta R2 papers · 2025
Department of Radiodiagnosis, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Papers in Europe PMC - 06Heinonen PK2 papers · 1997
Department of Obstetrics and Gynecology, Tampere University Hospital, Finland. KLPEHE@UTA.FI
Papers in Europe PMC - 07Hua K2 papers · 2024
Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University 419 Fang Xie Road, Shanghai 200090, China.
Papers in Europe PMC - 08Jain S2 papers · 2022
Department of Obstetrics & Gynecology, Institute of Medical Sciences, Banaras Hindu University, 221005, Varanasi, India.
Papers in Europe PMC - 09Liu J2 papers · 2025
Department of Ultrasonic Medicine, Changsha Maternal and Child Health Hospital, Changsha, China.
Papers in Europe PMC - 10Sharma S2 papers · 2023
Department of Minimally Invasive Gynaecology, Paras Hospitals, Gurugram, India.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
high confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Pseudounicornuate uterus" OR "Incomplete unilateral Müllerian aplasia" OR "Incomplete unilateral aplasia of the Müllerian ducts" OR "Incomplete unilateral aplasia of Müllerian ducts" OR "Unicornuate uterus with rudimentary horn" OR "incomplete unilateral Mullerian aplasia" OR "incomplete unilateral aplasia of the Mullerian ducts" OR "incomplete unilateral aplasia of Mullerian ducts"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Pseudounicornuate uterus" OR "Incomplete unilateral Müllerian aplasia" OR "Incomplete unilateral aplasia of the Müllerian ducts" OR "Incomplete unilateral aplasia of Müllerian ducts" OR "Unicornuate uterus with rudimentary horn" OR "incomplete unilateral Mullerian aplasia" OR "incomplete unilateral aplasia of the Mullerian ducts" OR "incomplete unilateral aplasia of Mullerian ducts"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T08:56:53.879Z